182 related articles for article (PubMed ID: 36208627)
1. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation.
Hou T; Tian Y; Cao Z; Zhang J; Feng T; Tao W; Sun H; Wen H; Lu X; Zhu Q; Li M; Lu X; Liu B; Zhao Y; Yang Y; Zhu WG
Mol Cell; 2022 Nov; 82(21):4099-4115.e9. PubMed ID: 36208627
[TBL] [Abstract][Full Text] [Related]
2. SIRT6: therapeutic target for nonalcoholic fatty liver disease.
Zang M; Gao B
Trends Endocrinol Metab; 2022 Dec; 33(12):801-803. PubMed ID: 36328906
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health.
Dong XC
Cells; 2023 Feb; 12(4):. PubMed ID: 36831330
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.
Zhu Y; Hu S; Pan X; Gopoju R; Cassim Bawa FN; Yin L; Xu Y; Zhang Y
Cells; 2023 Aug; 12(15):. PubMed ID: 37566087
[TBL] [Abstract][Full Text] [Related]
6. [The role of SIRT6 in nonalcoholic steatohepatitis].
Jing XD; Tang Q; He JH
Sheng Li Xue Bao; 2021 Oct; 73(5):745-754. PubMed ID: 34708231
[TBL] [Abstract][Full Text] [Related]
7. Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis.
Bang IH; Kwon OK; Hao L; Park D; Chung MJ; Oh BC; Lee S; Bae EJ; Park BH
Exp Mol Med; 2019 Sep; 51(9):1-11. PubMed ID: 31541078
[TBL] [Abstract][Full Text] [Related]
8. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
11. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake.
Nie K; Gao Y; Chen S; Wang Z; Wang H; Tang Y; Su H; Lu F; Dong H; Fang K
Phytomedicine; 2023 Mar; 111():154661. PubMed ID: 36682299
[TBL] [Abstract][Full Text] [Related]
13. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
14. Human centenarian-associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids.
Frohlich J; Raffaele M; Skalova H; Leire E; Pata I; Pata P; Gorbunova V; Vinciguerra M
Geroscience; 2023 Apr; 45(2):1177-1196. PubMed ID: 36534275
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice.
Nassir F; Arndt JJ; Johnson SA; Ibdah JA
J Lipid Res; 2018 Jun; 59(6):967-973. PubMed ID: 29581157
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.
Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ
Mol Cell Biol; 2016 Oct; 36(20):2553-67. PubMed ID: 27457618
[TBL] [Abstract][Full Text] [Related]
17. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
18. More than just a histone deacetylase: cytoplasmic SIRT6 facilitates fatty acid oxidation through ACSL5 deacetylation.
Li S; Yuan Z
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):525-527. PubMed ID: 36880305
[No Abstract] [Full Text] [Related]
19. Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12.
Li L; Zeng J; Zhang X; Feng Y; Lei JH; Xu X; Chen Q; Deng CX
EMBO Rep; 2024 Mar; 25(3):1361-1386. PubMed ID: 38332150
[TBL] [Abstract][Full Text] [Related]
20. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]